Immunoprecise Antibodies Ltd.
13F holders, Q1 2024 (March 31)22holders
1famous investor
$1.52avg. 13F price*
At the end of Q1 2024, 22 institutions reported holding Immunoprecise Antibodies Ltd. in their 13F filings. The largest holders were Ingalls & Snyder LLC ($2.0M), Bank of Montreal ($84K) and Northern Trust Corp. ($82K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Immunoprecise Antibodies Ltd.
- CUSIP
- 45257F200
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $86K |
| Exits | 6 | $271K |
Ownership 22 holders
| Ingalls & Snyder LLC | 0.09% | Add +0.6% | 1,288,535 | $2.0M |
| Bank of Montreal | 0.00% | Add +13.2% | 53,805 | $84K |
| Northern Trust Corp. | 0.00% | Reduce -11.4% | 53,950 | $82K |
| Cibc World Market Inc. | 0.00% | No change | 41,200 | $63K |
| Renaissance Technologies | 0.00% | Add +63.5% | 37,600 | $57K |
| Susquehanna International Group, LLP | 0.00% | New | 32,989 | $50K |
| Gradient Capital Advisors, LLC | 0.01% | No change | 26,808 | $41K |
| Two Sigma Securities, LLC | 0.00% | New | 23,352 | $35K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +11.6% | 22,033 | $33K |
| Royal Bank of Canada | 0.00% | Add +467.9% | 17,599 | $27K |
| Geode Capital Management, LLC | 0.00% | No change | 17,484 | $27K |
| Rathbones Group PLC | 0.00% | No change | 14,000 | $21K |
| Dimensional Fund Advisors LP | 0.00% | No change | 12,213 | $19K |
| Morgan Stanley | 0.00% | No change | 10,533 | $16K |
| Mariner, LLC | 0.00% | No change | 10,000 | $15K |
| Group One Trading LLC | 0.00% | No change | 3,779 | $6K |
| UBS Group AG | 0.00% | Reduce -76.8% | 2,478 | $4K |
| West Paces Advisors Inc. | 0.00% | No change | 1,665 | $3K |
| National Bank of Canada | 0.00% | No change | 1,540 | $2K |
| Simplex Trading, LLC | 0.00% | Reduce -62.1% | 1,004 | $1K |
| Citigroup Inc. | 0.00% | No change | 7 | $11 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3 | $5 |
"% of holder's portfolio" is IMMUNOPRECISE ANTIBODIES LTD's weight in each manager's 13F, not the share of Immunoprecise Antibodies Ltd. the manager owns.